A detailed history of Bi Asset Management Fondsmaeglerselskab A transactions in Biogen Inc. stock. As of the latest transaction made, Bi Asset Management Fondsmaeglerselskab A holds 7,171 shares of BIIB stock, worth $1.13 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,171
Previous 5,894 21.67%
Holding current value
$1.13 Million
Previous $1.37 Million 1.76%
% of portfolio
0.02%
Previous 0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$189.07 - $236.8 $241,442 - $302,393
1,277 Added 21.67%
7,171 $1.39 Million
Q2 2024

Aug 14, 2024

BUY
$190.52 - $236.72 $73,350 - $91,137
385 Added 6.99%
5,894 $1.37 Million
Q1 2024

May 03, 2024

SELL
$212.02 - $267.71 $53,853 - $67,998
-254 Reduced 4.41%
5,509 $1.19 Million
Q4 2023

Feb 09, 2024

SELL
$222.59 - $267.94 $170,058 - $204,706
-764 Reduced 11.71%
5,763 $1.49 Million
Q3 2023

Nov 13, 2023

SELL
$253.3 - $285.89 $306,493 - $345,926
-1,210 Reduced 15.64%
6,527 $1.68 Million
Q2 2023

Aug 03, 2023

BUY
$275.25 - $318.06 $456,364 - $527,343
1,658 Added 27.27%
7,737 $2.2 Million
Q1 2023

May 12, 2023

BUY
$256.56 - $292.34 $559,044 - $637,008
2,179 Added 55.87%
6,079 $1.69 Million
Q4 2022

Feb 13, 2023

BUY
$252.44 - $306.72 $692,947 - $841,946
2,745 Added 237.66%
3,900 $1.08 Million
Q3 2022

Nov 07, 2022

BUY
$194.69 - $268.46 $147,964 - $204,029
760 Added 192.41%
1,155 $308,000
Q2 2022

Aug 12, 2022

BUY
$187.54 - $223.02 $74,078 - $88,092
395 New
395 $81,000
Q1 2022

May 11, 2022

SELL
$193.77 - $244.14 $440,051 - $554,441
-2,271 Closed
0 $0
Q3 2021

Nov 09, 2021

SELL
$282.99 - $369.05 $243,937 - $318,121
-862 Reduced 27.51%
2,271 $643,000
Q1 2021

May 10, 2021

SELL
$242.95 - $284.63 $4.32 Million - $5.06 Million
-17,790 Reduced 85.03%
3,133 $876,000
Q4 2020

Feb 12, 2021

SELL
$236.26 - $355.63 $5.98 Million - $9 Million
-25,317 Reduced 54.75%
20,923 $5.12 Million
Q3 2020

Nov 09, 2020

BUY
$264.77 - $305.71 $1.71 Million - $1.98 Million
6,461 Added 16.24%
46,240 $13.1 Million
Q2 2020

Aug 05, 2020

BUY
$258.66 - $342.55 $5.82 Million - $7.71 Million
22,511 Added 130.36%
39,779 $10.6 Million
Q1 2020

May 11, 2020

BUY
$268.85 - $341.04 $520,493 - $660,253
1,936 Added 12.63%
17,268 $5.46 Million
Q4 2019

Mar 19, 2020

SELL
$220.06 - $304.07 $2.19 Million - $3.02 Million
-9,938 Reduced 39.33%
15,332 $4.55 Million
Q3 2019

Mar 19, 2020

BUY
$217.44 - $243.88 $4.54 Million - $5.09 Million
20,870 Added 474.32%
25,270 $5.88 Million
Q2 2019

Mar 19, 2020

BUY
$219.29 - $241.72 $964,876 - $1.06 Million
4,400 New
4,400 $1.03 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Bi Asset Management Fondsmaeglerselskab A Portfolio

Follow Bi Asset Management Fondsmaeglerselskab A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bi Asset Management Fondsmaeglerselskab A, based on Form 13F filings with the SEC.

News

Stay updated on Bi Asset Management Fondsmaeglerselskab A with notifications on news.